SCHEMBL10242676

SCHEMBL10242676

O=C1c2ccc(-c3ccccc3)cc2CCN1CCN1CCC(O)CC1

nearest known ligand 0.77

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 20/20 0.77
KCNH2 Q12809 5/20 0.59
HTR1A P08908 1/20 0.58
SLC6A4 P31645 1/20 0.58
HRH1 P35367 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3646548 0.87 HRH3 (1.00) HRH3KCNH2HTR1A
SCHEMBL8154261 0.87 HRH3 (0.95) HRH3KCNH2HTR1A
SCHEMBL8160743 0.86 HRH3 (0.57) HRH3KCNH2HTR1ASLC6A4HRH1
SCHEMBL8162038 0.85 HRH3 (0.82) HRH3KCNH2HTR1A
SCHEMBL504310 0.84 GRM5 (0.78) HRH3
SCHEMBL10242687 0.82 HRH3 (0.55) HRH3KCNH2HTR1ASLC6A4HRH1
SCHEMBL8159331 0.79 HRH3 (0.73) HRH3KCNH2
SCHEMBL28836299 0.78 HRH3 (0.71) HRH3KCNH2
SCHEMBL8155724 0.78 GRM5 (0.68) HRH3KCNH2
SCHEMBL29783123 0.78 HRH3 (0.71) HRH3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120028955-A1 BICYCLIC MGLUR5 POSITIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING SAME VANDERBILT UNIVERSITY 2012-02-02 US disclosed
US-20120028956-A1 BICYCLIC MGLUR5 POSITIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING SAME VANDERBILT UNIVERSITY 2012-02-02 US disclosed
US-8034806-B2 Bicyclic mGluR5 positive allosteric modulators and methods of making and using same VANDERBILT UNIVERSITY (US) 2011-10-11 US disclosed
US-20090270362-A1 BICYCLIC MGLUR5 POSITIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING SAME VANDERBILT UNIVERSITY 2009-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120028955-A1 BICYCLIC MGLUR5 POSITIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING SAME GRM5, GRIK5, GRM1 HRH3 838/4885KCNH2 903/4885HTR1A 123/4885
US-20120028956-A1 BICYCLIC MGLUR5 POSITIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING SAME GRM5, GRIK5, GRM1 HRH3 838/4885KCNH2 903/4885HTR1A 123/4885
US-20090270362-A1 BICYCLIC MGLUR5 POSITIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING SAME GRM5, GRIK5, GRM1 HRH3 838/4885KCNH2 903/4885HTR1A 123/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.